Latest Women's Hospital Stories
More than 85,000 medications are discontinued each year by physicians, yet while physicians share this information with their patients, it is too often not shared with the pharmacists.
A research team at Brigham and Women's Hospital has developed a novel device that may one day have broad therapeutic and diagnostic uses in the detection and capture of rare cell types, such as cancer cells, fetal cells, viruses and bacteria.
Commercial medical tapes on the market today are great at keeping medical devices attached to the skin, but often can do damage—such as skin tissue tearing—once it's time to remove them.
All major clinical trials now include disclosures detailing who funded the study to ensure transparency.
Each year, nearly 2 million people die from tuberculosis – a treatable disease that has been brought under control in the United States, but continues to ravage other parts of the world.
Migraines currently affect about 20 percent of the female population, and while these headaches are common, there are many unanswered questions surrounding this complex disease.
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
A research team led by Xian Chang Li, MD, PhD, Brigham and Women's Hospital (BWH) Transplantation Research Center, has shed light on how a population of lymphocytes, called CD4+ T cells, mature into various subsets of adult T helper cells.
Researchers from Brigham and Women's Hospital in Boston have found that the longer a person stays awake, the more trouble he or she will have performing certain types of tasks.
- A political dynamiter.